非小细胞肺癌

支气管动脉灌注加栓塞治疗非小细胞肺癌的价值

Value of Bai combined with BAE for the treatment of advanced NSCLC

方法：60名Ⅲb、Ⅳ期非小细胞肺癌患者随机分到治疗组和对照组。

METHODS : A total of 60 eligible patients with advanced NSCLC were randomly assigned to treatment group and control group .

非小细胞肺癌血管生成的MR动态增强研究

Clinical Study of Tumor Angiogenesis with Dynamic Contrast-enhanced MR Imaging in Non-small-Cell-Lung-Cancer

非小细胞肺癌中的DNA相对含量预后意义的研究

Prognostic Significance of DNA Relative Content in Non-small Cell Lung Carcinoma

一例ⅡB期非小细胞肺癌术后患者的循证治疗

Evidence-based Treatment for a Patient of ⅱ B Stage Non-Small Cell Lung Cancer

可切除Ⅲ期N2非小细胞肺癌治疗共识与争议

Controversy in The Treatment of Resectable Stage ⅲ - N2 Non-small Cell Lung Cancer

X刀立体定向放射治疗非小细胞肺癌的临床研究

Clinical study on treatment of non-small cell lung cancer with X-knife stereotactic radiotherapy

云锡矿工非小细胞肺癌形态计量和DNA定量检测研究

Cellular morphometry and DNA content measurements of non-small-cell lung cancer of miners in Yunnan Tin Mine

非小细胞肺癌p53基因治疗的循证医学评价

Evidence-based Appraisal of p53 Gene Therapy for Non-Small Cell Lung Cancer

非小细胞肺癌的CT增强值与p53表达的关系研究

The Relationship between CT Enhancement Value and p53 Protein Expression in Nonsmall cell Lung Cancer

动态增强MRI在评价非小细胞肺癌分期中的临床价值

Clinical Evaluation of dynamic contrast-enhanced MR imaging in the staging of non-small cell lung cancer

非小细胞肺癌肿瘤血管生成与动态增强MRI表现的相关性

Tumor Angiogenesis and Dynamic Contrast-enhanced MR Imaging in Non-small Cell Lung Cancer : Imaging-Pathologic Correlation

方法应用CAS&200型图像细胞仪对22例非小细胞肺癌纤支镜活检标本和相应手术标本进行DNA含量分析和比较研究。

Methods DNA content of bronchoscopic biopsy specimens and corresponding surgical specimens was measured by using CAS-200 image cytometry .

CT引导下的肺部结节针吸活检结果为非小细胞肺癌。

CT-guided fine-needle aspiration of a lung nodule revealed cells consistent with non – small-cell carcinoma of the lung .

人非小细胞肺癌中蛋白激酶CβⅠ的表达及细胞凋亡与预后关系的研究

Relationship between protein kinase C βⅰ ( PKC - βⅰ) expression , apoptosis and prognosis in patients with non-small cell lung cancer

非小细胞肺癌转移预测指标的Logistic回归分析

Logistic Regression of Prognostic Prediction of Metastasis in Patients with Non-Small Cell Lung Cancer

非小细胞肺癌动态CT增强值与正电子发射计算机体层摄影脱氧葡萄糖标准摄取值的相关性探讨

Correlative investigation of dynamic contrast CT and positron emission tomography with 18-fluorodeoxy glucose standardized uptake value in non-small cell lung cancer

国产药VC方案与GC方案治疗晚期非小细胞肺癌的对比观察

Comparative Study of VC and GC Regimen in Advanced Stage Nonsmall Cell lung Cancer

实时荧光定量PCR及免疫组化检测非小细胞肺癌中Survivin表达及意义

Real-time PCR and Immunohistochemistry Detecting the Expression of Survivin in NSCLC and the Clinical Significance

非小细胞肺癌PCNA、ki-67和p53表达的研究

Expression of PCNA 、 Ki-67 and P53 in Nonsmall Cell Lung Cancer

目的探讨肝素酶基因及血管内皮生长因子（VEGF）在非小细胞肺癌（NSCLC）中的表达及其临床病理学意义。

Objective To study the clinicopathological significance of heparanase and VEGF expression in NSCLC .

vEGFmRNA、KDRmRNA及蛋白在非小细胞肺癌中表达的意义探讨

Significance of expression of VEGF mRNA , KDR mRNA and corresponding proteins in non-small cell lung cancer

口服VP（16）联合DDP方案治疗非小细胞肺癌

Oral VP 16 Plus DDP Regimen for Non small Cell Lung Cancer

非小细胞肺癌组织中KAI1/CD（82）和P53的表达及临床意义

Expression and clinicopathologic significance of KAI1 / CD_ ( 82 ) and P53 gene protein in Non-small cell lung cancer

EGFR突变与非小细胞肺癌酪氨酸激酶抑制剂靶向治疗

EGFR mutations and targeted therapy with tyrosine kinases inhibitors in non-small cell lung cancer

方法：将40例晚期（Ⅲb期、Ⅳ期）非小细胞肺癌患者随机分为2组，均使用NP化疗方案。

Methods : 40 cases of ⅲ b and ⅳ stage of NSCLC were allocated to 2 groups randomly with NP chemotherapy programme .

Survivin、P53、Bcl-2蛋白与非小细胞肺癌临床病理因素的关系

The relationship between expression of survivin , P53 , Bcl-2 with the clinicopathologic factors in non-small cell lung cancer

伴神经内分泌分化非小细胞肺癌中p53、bcl-2及c-myc的表达

Study on the specific expressions of p53 , bcl-2 and c-myc in non-small cell lung cancer with neuroendocrine differentiation

COX-2可能通过促进肿瘤的血管和淋巴管形成而参与了非小细胞肺癌细胞的浸润和转移。

COX-2 may participate in the metastasis of non-small cell lung cancer through promoting vascularization in the tumors .

非小细胞肺癌病灶中p53、ki-67以及p21的表达和淋巴结微转移灶之间的关系

Relationship Between p53 , ki-67 , p21 and Micrometastasis in Lymph nodes of Patients with Non-small-cell Lung Cancer